Replies to post #404192 on Innovation Pharmaceuticals Inc (IPIX)

[sunspotter]

“ I consider my investment to be more in BeaMed at this point than in IPIX given that we own a substantial interest in that company.”

Betcha don’t own any BeaMed any more.

Leo is delaying because he still has some assets to stealthily transfer before bankruptcy is declared.

[leavetheguntakethecannolis]

Agreed. Beamed definitely has much more potential for near term financial impact on shareholders.

The market need for new laser-based surgical technologies is significant. We fully expect BeaMed to capitalize on this opportunity as it positions itself for FDA submission by the middle of 2024,” commented Leo Ehrlich, Chief Executive Officer at Innovation Pharmaceuticals.

“BeaMed remains steadfast in its commitment to help patients suffering from current gaps in care,” said Gil Shapira, Co-Founder of BeaMed. “Our goal with the StingRay system is to commercialize a novel technology to treat previous inoperable cases of epilepsy and improve outcomes in other surgical-based oncology procedures. It’s exciting to think that in approximately one year this may be a reality.”

BeaMed has informed the Company that it has initiated important software integration work; engaged regulatory agencies on appropriate development steps via the 510(k) pathway; formalized a distribution relationship with Fortec Medical (www.fortecmedical.com), which has access to over 2700 hospitals in the U.S.; and identified key opinion leaders to serve in scientific advisory capacities.